| Product Code: ETC11944687 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
4 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity, type II diabetes, and NASH in Israel |
4.2.2 Growing awareness about minimally invasive endoscopic procedures for these conditions |
4.2.3 Technological advancements in endoscopy devices improving their efficacy and safety |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of endoscopy devices in Israel |
4.3.2 Limited healthcare reimbursement for endoscopic procedures targeting obesity, type II diabetes, and NASH |
4.3.3 High initial investment costs associated with acquiring endoscopy devices |
5 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Types |
6.1 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscope, 2021 - 2031F |
6.1.4 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Mechanical endoscopic equipment, 2021 - 2031F |
6.1.5 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Visualization and documentation systems, 2021 - 2031F |
6.1.6 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Accessories, 2021 - 2031F |
6.1.7 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Other endoscopy equipment , 2021 - 2031F |
6.2 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric balloon, 2021 - 2031F |
6.2.3 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Aspiration therapy, 2021 - 2031F |
6.2.4 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscopic sleeve gastroplasty, 2021 - 2031F |
6.2.5 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric injection, 2021 - 2031F |
6.2.6 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Lap band surgery , 2021 - 2031F |
6.3 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Obesity , 2021 - 2031F |
6.3.3 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Type II Diabetes , 2021 - 2031F |
6.3.4 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2021 - 2031F |
7 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Import-Export Trade Statistics |
7.1 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Export to Major Countries |
7.2 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Imports from Major Countries |
8 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
8.1 Adoption rate of endoscopy devices for obesity, type II diabetes, and NASH procedures in Israel |
8.2 Rate of technological innovation and new product launches in the endoscopy market |
8.3 Patient outcomes and satisfaction levels post-endoscopic procedures for obesity, type II diabetes, and NASH |
9 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
9.1 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
10.1 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2024 |
10.2 Israel Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here